deferiprone has been researched along with acetylcysteine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Chevanne, M; Cillard, J; Cillard, P; Morel, I; Sergent, O; Sinbandhit-Tricot, S | 1 |
| Amer, J; Fibach, E; Ghoti, H; Rachmilewitz, E; Winder, A | 1 |
| Chattipakorn, N; Chattipakorn, SC; Fucharoen, S; Khamseekaew, J; Kumfu, S; Srichairatanakool, S; Sripetchwandee, J; Wongjaikam, S | 1 |
| Chokchaichamnankit, D; Hatairaktham, S; Kalpravidh, RW; Masaratana, P; Panachan, J; Panichkul, N; Srisomsap, C; Svasti, J; Weeraphan, C | 1 |
| Kontoghiorghe, CN; Kontoghiorghes, GJ | 1 |
| Chattipakorn, N; Chattipakorn, SC; Fucharoen, S; Khamseekaew, J; Kumfu, S; Siri-Angkul, N; Sumneang, N | 1 |
1 review(s) available for deferiprone and acetylcysteine
| Article | Year |
|---|---|
Prospects for the introduction of targeted antioxidant drugs for the prevention and treatment of diseases related to free radical pathology.
Topics: Acetylcysteine; Animals; Antioxidants; Deferiprone; Drug Design; Drug Development; Free Radical Scavengers; Free Radicals; Humans; Iron Chelating Agents; Molecular Targeted Therapy; Oxidative Stress | 2019 |
1 trial(s) available for deferiprone and acetylcysteine
| Article | Year |
|---|---|
Differentially expressed plasma proteins of β-thalassemia/hemoglobin E patients in response to curcuminoids/vitamin E antioxidant cocktails.
Topics: Acetylcysteine; Adult; beta-Thalassemia; Blood Proteins; Curcumin; Deferiprone; Drug Therapy, Combination; Female; Free Radical Scavengers; Gene Expression Regulation; Hemoglobin E; Humans; Male; Vitamin E | 2019 |
6 other study(ies) available for deferiprone and acetylcysteine
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Glutathione depletion increases nitric oxide-induced oxidative stress in primary rat hepatocyte cultures: involvement of low-molecular-weight iron.
Topics: Acetylcysteine; Animals; Buthionine Sulfoximine; Cells, Cultured; Deferiprone; Ditiocarb; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Glutathione; Hepatocytes; Interferon-gamma; Iron; Iron Chelating Agents; Lipid Peroxidation; Lipopolysaccharides; Liver; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Oxidative Stress; Pyridones; Rats; Rats, Sprague-Dawley | 2003 |
Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Antioxidants; Blood Platelets; Chelating Agents; Deferiprone; Deferoxamine; Erythrocytes; Female; Humans; Male; Myelodysplastic Syndromes; Neutrophils; Oxidative Stress; Pyridones | 2007 |
Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats.
Topics: Acetylcysteine; Animals; Benzoates; Cardiomyopathies; Cardiotonic Agents; Deferasirox; Deferiprone; Deferoxamine; Drug Combinations; Drug Synergism; Humans; Iron; Iron Chelating Agents; Iron Overload; Iron, Dietary; Male; Malondialdehyde; Mitochondria; Pyridones; Rats; Rats, Wistar; Triazoles; Ventricular Function, Left | 2016 |
Combined iron chelator with N-acetylcysteine exerts the greatest effect on improving cardiac calcium homeostasis in iron-overloaded thalassemic mice.
Topics: Acetylcysteine; Animals; Calcium; Deferiprone; Heart; Homeostasis; Iron Chelating Agents; Iron Overload; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Thalassemia; Ventricular Function, Left | 2019 |